Tailored Drug Titration Using Artificial Intelligence

NACompletedINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

February 18, 2020

Primary Completion Date

December 30, 2022

Study Completion Date

June 27, 2023

Conditions
Hypertension
Interventions
OTHER

optima4BP

"optima4BP establishes a no gaps computational framework in determining the most effective treatment change that can optimize a patient's HTN management towards BP Target. All possible drug combination options available through the 16 anti-HTN drug classes and subclasses are quantitatively evaluated in the context of 5 actions: add a drug, remove a drug, replace a drug, increase a drug dose, and decrease a drug dose. The pharmacological intervention efficacy ranking is computed and the highest ranked treatment recommendation is selected for consideration by the treating physician."

Trial Locations (1)

94143

University of California San Francisco, San Francisco

Sponsors
All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

lead

Optima Integrated Health

INDUSTRY

NCT04223934 - Tailored Drug Titration Using Artificial Intelligence | Biotech Hunter | Biotech Hunter